台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商惠氏藥廠（亞洲）股份有限公司台灣分公司 台北市信義區松仁路100號42、43樓 (23984410) - pneumococcal polysaccharide serotype 1;;pneumococcal polysaccharide serotype 3;;pneumococcal polysaccharide serotype 4;;pneumococcal polysaccharide serotype 5;;pneumococcal polysaccharide serotype 6a;;pneumococcal polysaccharide serotype 6b;;pneumococcal polysaccharide serotype 7f;;pneumococcal polysaccharide serotype 9v;;pneumococcal polysaccharide serotype 14;;oligosaccharide serotype 18c;;pneumococcal polysaccharide serotype 19a;;pneumococcal polysaccharide serotype 19f;;pneumococcal polysaccharide serotype 23f;;crm197 carrier protein - 滅菌懸液注射劑 - 主成分 (quantity per dose (0.5ml)) ; crm197 carrier protein (1600001310) ~ug; pneumococcal polysaccharide serotype 1 (8012012100) ug; pneumococcal polysaccharide serotype 4 (8012012200) ug; pneumococcal polysaccharide serotype 5 (8012012300) ug; pneumococcal polysaccharide serotype 6b (8012012400) ug; pneumococcal polysaccharide serotype 6a (8012012420) ug; pneumococcal polysaccharide serotype 7f (8012012500) ug; pneumococcal polysaccharide serotype 9v (8012012600) ug; pneumococcal polysaccharide serotype 14 (8012012700) ug; pneumococcal polysaccharide serotype 19f (8012012900) ug; pneumococcal polysaccharide serotype 19a (8012012920) ug; pneumococcal polysaccharide serotype 23f (8012013000) ug; pneumococcal polysaccharide serotype 3 (8012013100) ug; oligosaccharide serotype 18c (9900016520) ug - pneumococcus, purified polysaccharides antigen conjugated - 可用於出生2個月至17歲嬰兒及兒童與青少年的主動免疫接種，以預防血清型1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f及23f肺炎鏈球菌(streptococcus pneumoniae)引起的侵入性疾病。沛兒肺炎鏈球菌十三價結合型疫苗也可用於預防2歲以下嬰幼兒血清型4, 6b, 9v, 14, 18c, 19f及23f肺炎鏈球菌引起的中耳炎。本疫苗可用於18歲(含)以上之成人與老年人的主動免疫接種，以預防血清型1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f及23f肺炎鏈球菌引起的侵入性疾病和肺炎。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商惠氏藥廠（亞洲）股份有限公司台灣分公司 新北市淡水區中正東路二段177號 (23984410) - polysaccharide serotype;;polysaccharide serotype;;polysaccharide serotype;;polysaccharide serotype;;oligosaccharide serotype 18c;;polysaccharide serotype;;polysaccharide serotype;;crm197 carrier protein - 注射劑 - crm197 carrier protein (1600001310) mcg; polysaccharide serotype (9200022020) (19f)mcg; polysaccharide serotype (9200022020) (23f)mcg; polysaccharide serotype (9200022020) (4)mcg; polysaccharide serotype (9200022020) (6b)mcg; polysaccharide serotype (9200022020) (9v)mcg; polysaccharide serotype (9200022020) (14)mcg; oligosaccharide serotype 18c (9900016520) mcg - pneumococcal vaccines - 預防莢膜血清型(4, 6b, 9v, 14, 18c, 19f和23f)的肺炎鏈球菌所引起的侵入性疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720) - pneumococcal polysaccharide serotype 1;;pneumococcal polysaccharide serotype 3;;pneumococcal polysaccharide serotype 4;;pneumococcal polysaccharide serotype 5;;pneumococcal polysaccharide serotype 6a;;pneumococcal polysaccharide serotype 6b;;pneumococcal polysaccharide serotype 7f;;pneumococcal polysaccharide serotype 9v;;pneumococcal polysaccharide serotype 14;;oligosaccharide serotype 18c;;pneumococcal polysaccharide serotype 19a;;pneumococcal polysaccharide serotype 19f;;pneumococcal polysaccharide serotype 22f;;pneumococcal polysaccharide serotype 23f;;pneumococcal polysaccharide serotype 33f;;crm197 carrier protein - 滅菌懸液注射劑 - pneumococcal polysaccharide serotype 1 (8012012100) ug; pneumococcal polysaccharide serotype 4 (8012012200) ug; pneumococcal polysaccharide serotype 5 (8012012300) ug; pneumococcal polysaccharide serotype 6b (8012012400) ug; pneumococcal polysaccharide serotype 6a (8012012420) ug; pneumococcal polysaccharide serotype 7f (8012012500) ug; pneumococcal polysaccharide serotype 9v (8012012600) ug; pneumococcal polysaccharide serotype 14 (8012012700) ug; pneumococcal polysaccharide serotype 19f (8012012900) ug; pneumococcal polysaccharide serotype 19a (8012012920) ug; pneumococcal polysaccharide serotype 23f (8012013000) ug; pneumococcal polysaccharide serotype 3 (8012013100) ug; pneumococcal polysaccharide serotype 22f (8012013200) ug; pneumococcal polysaccharide serotype 33f (8012013300) ug; oligosaccharide serotype 18c (9900016520) ug; crm197 carrier protein (1600001310) ug - pneumococcus, purified polysaccharides antigen conjugated - 適用於6週以上兒童及成人的主動免疫接種，以預防由肺炎鏈球菌血清型1、3、4、5、6a、6b、7f、9v、14、18c、19a、19f、22f、23f和33f所引起的侵襲性疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - pneumococcal polysaccharide serotype 1;;pneumococcal polysaccharide serotype 4;;pneumococcal polysaccharide serotype 5;;pneumococcal polysaccharide serotype 6b;;pneumococcal polysaccharide serotype 7f;;pneumococcal polysaccharide serotype 9v;;pneumococcal polysaccharide serotype 14;;pneumococcal polysaccharide serotype 18c;;pneumococcal polysaccharide serotype 19f;;pneumococcal polysaccharide serotype 23f;;carrier protein (protein d (pd));;carrier protein (tetanus toxoid (tt));;carrier protein (diphtheria toxoid (dt)) - 主成分 () ; carrier protein (protein d (pd)) (8008001000) 9-16ug; carrier protein (tetanus toxoid (tt)) (8008001100) 5-10ug; carrier protein (diphtheria toxoid (dt)) (8008001300) 3-6ug; pneumococcal polysaccharide serotype 1 (8012012100) ug; pneumococcal polysaccharide serotype 4 (8012012200) ug; pneumococcal polysaccharide serotype 5 (8012012300) ug; pneumococcal polysaccharide serotype 6b (8012012400) ug; pneumococcal polysaccharide serotype 7f (8012012500) ug; pneumococcal polysaccharide serotype 9v (8012012600) ug; pneumococcal polysaccharide serotype 14 (8012012700) ug; pneumococcal polysaccharide serotype 18c (8012012800) ug; pneumococcal polysaccharide serotype 19f (8012012900) ug; pneumococcal polysaccharide serotype 23f (8012013000) ug - pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated - 6週至5歲大嬰兒與幼兒之主動免疫接種，預防由肺炎鏈球菌血清型1、4、5、6b、7f、9v、14、18c、19f和23f所引起的侵襲性肺炎鏈球菌感染、肺炎與急性中耳炎。對於交叉反應血清型所引起的侵襲性肺炎鏈球菌感染症之部分保護力請參見藥效學段落。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720) - capsular polysaccharide purified - 注射劑 - capsular polysaccharide purified (8004003400) 50mcg/m - pneumococcus, purified polysaccharides antigen - 預防肺炎鏈球菌性肺炎及肺炎鏈球菌性菌血症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - immunoglobulin human - 注射液劑 - immunoglobulin human (8004000603) human plasma protein with at least 98% iggmg - immunoglobulins, normal human, for intravascular adm. - 作為替代療法：1.原發性免疫不全症(primary immunodeficiency syndromes，pid)如：(1)先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)及丙種免疫球蛋白過低症(hypogammaglobulinemia)(2)常見變異性免疫不全症(common variable immunodeficiency)(3)嚴重複合型免疫不全症(severe combined immunodeficiency)(4)wiskott- aldrich氏症候群2.慢性淋巴性白血病引致丙種免疫球蛋白過低與復發性細菌感染，且預防性抗生素治療無效的病人。3.多發性骨髓瘤穩定期(plateau phase)引致丙種免疫球蛋白過低與復發性細菌感染，且施打肺炎鏈球菌疫苗無效的病人。4.異體造血幹細胞移植後引致丙種免疫球蛋白過低。5.先天性愛滋病(aids)伴隨復發性細菌感染者。作為免疫調節：1.免疫性血小板缺乏紫斑症(immune thrombocytopenic purpura, itp)，且具高出血風險或用於手術前矯正血小板計數。2.格林-巴利症候群(guillain-barré syndrome)。3.川崎氏症(kawasaki disease) （與乙醯水楊酸acetylsalicylic acid一起使用；請參閱“劑量/用法”章節。）。4.慢性脫髓鞘多發性神經炎(chronic inflammatory demyelinating polyneuropathy, cidp)，對孩童的使用經驗有限。5.多灶性運動神經病變 (multifocal motor neuropathy, mmn)。6.重症肌無力惡化(myasthenia gravis exacerbations, mg)。7.藍伯-伊頓肌無力症(lambert-eaton myasthenic syndrome)。8.僵體徵候群(stiff person syndrome)。

中国 - 中文 - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 0.5ml/剂，含25μg多糖/型

中国 - 中文 - CFDA (药监局 - 中国食品和药物管理局)

赛诺菲巴斯德 - 注射剂 - 0.5ml/剂，含25μg多糖/型

中国 - 中文 - CFDA (药监局 - 中国食品和药物管理局)

sanofi pasteur s.a. - 注射剂 - 0.5ml/剂，含25μg多糖/型

中国 - 中文 - CFDA (药监局 - 中国食品和药物管理局)

merck sharp & dohme corp. - 注射剂 - 0.5ml/瓶